Vice President
SetPoint Medical
Ankit Shah has more than a decade of experience developing and commercializing innovative medical technology. He heads up commercialization at SetPoint Medical, a neuroimmune modulation company, that is transforming the treatment of chronic autoimmune conditions like Rheumatoid Arthritis, Inflammatory Bowel Disease and Multiple Sclerosis. He was a founding member of the commercialization team at Intersect ENT (NASDAQ: XENT) and held positions at Outset Medical, Medtronic, SV Health Investors and the FDA.
Neuromodulation for Internal Organs
Thursday, January 30, 2025
11:15 AM - 12:00 PM EST